Keywords
Sexual Function
Adverse Reactions
Oral Contraceptives
Polycystic Ovaries
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Investigate the effects of PCOS on the quality of life of women regarding the sexual function of those with PCOS who use oral contraceptives. Methods: This is a retrospective cohort epidemiologic study, applied in a virtual environment with 50 women with PCOS who use oral contraceptives. They were investigated for their sexual function using the Female Sexual Function Index (FSFI). Data obtained was analyzed by descriptive statistics with the aid of the. This study was approved by the Research Ethics Committee. Results: Of the 102 responses obtained, only 45 had been using oral contraceptives for more than 3 months and had PCOS. From those, 20 used oral contraceptives with a concentration of ethinyl estradiol greater than or equal to 0.035mg. Women who have PCOS and use contraceptives with this concentration obtained higher FSFI scores than those who use contraceptives with lower concentrations. The relative risk of exposure to concentrations greater than 0.035mg was 0.75. Conclusion: Oral contraceptives affect the sexual function of patients in different ways and PCOS is a factor that aggravates this situation. It is suggested that further investigations be carried out on the subject studied.
References
AMIRI M, et al. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health Qual Life Outcomes. 2020; 18(1): 293.
BAHAMONDES L e BAHAMONDES MV. New and emerging contraceptives: a state-of-the-art review. Int. J. Womens. Health. 2014; 6.
BARACAT MC e REZENDE GP. Qualidade de vida e função sexual em mulheres com SOP. In: Síndrome dos ovários policísticos. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO). 2023; 3: 46-64.
BERNARD L, et al. "Quality of life and psychological well being in polycystic ovary syndrome." Human reproduction. 2007; 8(6): 2279-2286.
CASADO-ESPADA NM, et al. Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review. J Clin Med. 2019; 25(8): 908.
CESTA CE, et al. Polycystic ovary syndrome and psychiatric disorders: Comorbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology. 2016; 73: 196-203.
DAVIS SR, et al. Endocrine aspects of female sexual dysfunction. J Sex Med. 2004; 1(1): 82-86.
FEBRASGO. Federação Brasileira das Associações de Ginecologia e Obstetrícia Tratado de Ginecologia. Rio de Janeiro: Grupo GEN. 2018; 998.
GOMES PD, et al. Contracepção hormonal: uma comparação entre pacientes das redes pública e privada de saúde. Ciênc. saúde coletiva. 2011; 16(5): 2453-2460.
HASEGAWA LEM, et al. A relação entre o uso de anticoncepcionais hormonais e a sexualidade feminina: uma revisão integrativa. Research, Society and Development. 2022; 11(4): e12711423238.
IMPRIALOS, K.P, et al. Sexual Dystunction, Cardiovascular Risk and Effects of Pharmacotherapy. Curr. Vasc. Pharmacol. 2018; 16: 130-142.
IZZO CR. Infertilidade de causa hormonal para o ginecologista. Boletim da SBRH. São Paulo. 2008; 6(2): 1-8.
LIDDELOW C, et al. Adherence to the oral contraceptive pill: the roles of health literacy and knowledge, Health Psychology and Behavioral Medicine. 2020; 8(1): 587-600.
MANTZOU D, et al. Sexual Function in Young Women With PCOS: The Detrimental Bffect of Anovulation. J Sex Med. 2021; 18(11): 1872-1879.
MEDEIROS AJG, et al. Abordagem do diagnóstico e tratamento da síndrome dos ovários policísticos. Revista Eletrônica Acervo Saúde. 2023; 23(8): e13503.
MURGEL FCA, et al. Sexual Dysfunction in Women With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. The Journal of Sexual Medicine. 2019; 16(4): 542-550.
PASTOOR H, et al. Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study. Sex Med. 2020; 8(4): 718-729.
POKORA K, et al. Depressive Symptoms and Control of Emotions among Polish Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health. 2022; 19(24): 16871.
RASHID RSA, et al. Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Tawainase Journal of Obstetrics & Gynecology. 2022; 61: 40-60.
MORAES LU, et al. As Bases do Diagnóstico Sindrômico. São Paulo: Editora Científica Digital. 2023; 1: 338p.
SHAKEEL M, et al. Sexual functioning as predictor of depressive symptoms and life satisfaction in females with Polycystic Ovary Syndrome (PCOS). Pakistan Journal of Medical Sciences. 2020; 36(7): 1500-1504.
SILVA RC, et al. Síndrome dos ovários policísticos, síndrome metabólica, risco cardiovascular e o papel dos agentes sensibilizadores da insulina. Arq Bras Endocrinol Metab, São Paulo. 2006; 50(2): 281-290.
SOUZA MS, et al. "Anticoncepcionais hormonais orais e seus efeitos colaterais no organismo feminino: uma revisão integrativa: Oral hormonal contraceptives and their effects colateral in the female organism: an integrative review." Journal of Education Science and Health 2.2. 2022; 01-11.
SPEER JJ, et al. Study of sexual functioning determinants in breast cancer survivors. Breast J. 2005; 11(6): 440-7.
SPRITZER PM. Polycystic ovary syndrome: new insights on the puzzle of adiposity, chronic low-grade inflammation and metabolic disturbances. Arch. Endocrinol. Metab. 2020; 64(1): 2-3.